Biomedica

What Biomedica does

Biomédica Equipamentos e Suprimentos Hospitalares Ltda. (operating as Biomedica) is a privately held Brazilian distributor of molecular diagnostic, ELISA, and rapid test solutions founded in 1996 in Brasília, Brazil. The company targets clinical and pathology laboratories in Brazil as a B2B distributor, employing between 11 and 50 people as part of a group of nine companies. Its core product lines span molecular biology equipment and reagents (including qPCR kits for infectious diseases, HPV, sexual health, oncology, and respiratory panels), ELISA immunoassays, rapid tests across fertility, infectious disease, cardiac markers, GMO, drug abuse, and food safety categories, and Chrono-log platelet aggregation solutions.

The company's central technology platform centers on the DT Prime I and II real-time PCR thermocyclers from DNA-Technology, controlled by the proprietary DNA-Thermo software. DT Prime systems offer 48- or 96-well block formats, up to six fluorescence channels for multiplex testing, native Wi-Fi/LAN connectivity on the DT Prime II, and bidirectional integration with Laboratory Information Systems (LIS). The software includes automated Ct and melting curve analysis, user permission controls, audit logging, and multi-format report exports (XML, CSV, PDF). The portfolio comprises 465 registered products with ANVISA certification and alignment to ISO 15189, PALC, and CAP laboratory accreditation standards.

Biomedica's revenue model combines one-time equipment sales (DT Prime thermocyclers) with recurring consumables revenue from PCR detection kits, extraction reagents, ELISA kits, and rapid tests. Sales are conducted through a direct B2B sales team supported by WhatsApp Business contact and website-based product catalogs, with no publicly disclosed pricing. In October 2025, the company extended beyond its domestic diagnostic distribution model by signing an exclusive agreement with Santhera Pharmaceuticals to distribute AGAMREE (vamorolone) for Duchenne muscular dystrophy in Russia, with sales expected to commence in Q1 2026, marking its first known international and pharmaceutical distribution operation.

Name

Biomedica

Legal name

Biomédica Equipamentos e Suprimentos Hospitalares Ltda.

Website

https://biomedica.com.br

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

11–50 employees

Short description

Biomedica is a privately held Brazilian distributor founded in 1996 that supplies molecular diagnostic equipment (including DNA-Technology's DT Prime PCR platform), reagents, ELISA kits, and rapid tests to clinical and pathology laboratories in Brazil, with recent expansion into Russia for AGAMREE distribution.

Ownership category

akta.pro rank

Product category

Molecular Diagnostics / In Vitro Diagnostics Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)

akta.pro secondary industries

Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC), Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing) (HLAAALAH), Microbiology & Infectious Disease Diagnostics (Culture/ID/AST) (HLAHAAAC)

Keywords

• Molecular diagnostics
• PCR equipment
• ELISA test kits
• Rapid diagnostic tests
• Laboratory reagents

Headquarters

HQ city

Brasilândia

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Diagnostic Equipment Sales: Sale of molecular diagnostic equipment including DT Prime thermal cyclers for real-time PCR applications to clinical laboratories.
2. Diagnostic Reagents and Kits: Sale of consumables including PCR detection kits (HPV, infectious diseases, respiratory panels), extraction reagents, and plastic consumables.
3. ELISA and Rapid Test Products: Sale of ELISA kits and rapid test products for various diagnostic applications including fertility, infectious diseases, cardiac markers, and food safety.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Biomedica distributes molecular diagnostic instruments and consumables — primarily DNA-Technology PCR thermal cyclers (DT Prime I/II) and qPCR detection kits, ELISA kits, rapid tests, and Chrono-log platelet aggregation systems — to clinical and pathology laboratories in Brazil. The company additionally distributes AGAMREE (vamorolone) into the Russian market.

Product overview

Biomedica is a Brazilian diagnostic intelligence company (Biomédica Equipamentos e Suprimentos Hospitalares Ltda.) founded in 1996, providing molecular diagnostic solutions for laboratory medicine. The portfolio centers on the DT Prime I and II real-time PCR thermocyclers from DNA-Technology, controlled by DNA-Thermo software, which form the core molecular biology platform. The company offers complementary product lines including Femoflor® 16 and HPV-QUANT-21® PCR detection kits, rapid tests across fertility, infectious diseases and food safety categories, ELISA immunoassay products, and Chrono-log platelet aggregation solutions. Biomedical also distributes Santhera's AGAMREE® (vamorolone) for Duchenne muscular dystrophy in Russia. The product ecosystem is supported by supplier partnerships including Certest Biotec, CW Bio, DNA Technology, HiMedia Laboratories, PlexBio, Tanbead, Zeesan Biotech, and BD (Becton Dickinson), with ANVISA-registered products and compliance with ISO 15189, PALC, and CAP quality standards.

Differentiator

Problem solved

Functional benefit

Products and services

• DT Prime I Real-Time PCR Thermal Cycler

Quantifiable outcome

• Up to 60% reduction in processing time when transitioning from hybrid capture to PCR with DT Prime
• +1 more outcomes

Named customers2 records

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature6 records

Partnerships

Two partnerships are on record, tiered core.

• Santhera PharmaceuticalscoreChannel Partner/ Reseller/ Distributor · 9 October 2025Biomedica entered an exclusive distribution agreement with Santhera Pharmaceuticals for the distribution of AGAMREE (vamorolone) in Russia. The partnership facilitates access to the drug for approximately 1,400 Duchenne muscular dystrophy patients in Russia, with sales expected to begin in Q1 2026. This is part of Santhera's broader global expansion efforts.
• DNA-TechnologycoreTechnology or IntegrationBiomedica is the official distributor of DNA-Technology products in Brazil, including the DT Prime I and II real-time PCR thermal cyclers. The partnership includes technical support, training, equipment validation, and protocol customization for laboratories in Brazil.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Celer Biotecnologia: Brazilian diagnostic distributor offering molecular biology, ELISA, and rapid test reagents to clinical laboratories; competes directly with Biomedica on PCR kits and lab supply contracts in Brazil.
• Diagnóstica Brasil: Brazilian distributor of in-vitro diagnostics and laboratory reagents serving clinical and hospital labs with a comparable portfolio to Biomedica across molecular and immunological testing.

Regional players

• Labtest Diagnóstica: Brazilian IVD manufacturer and distributor focused on clinical chemistry, hematology, and immunoassay reagents, competing with Biomedica's ELISA and rapid test lines for the same Brazilian lab customers.
• Gold Analisa Diagnóstica: Brazilian manufacturer and distributor of clinical chemistry, immunoassay, and rapid diagnostic reagents; a regional peer overlapping with Biomedica's ELISA and clinical lab offering in Brazil.
• Wiener lab: Argentine-headquartered IVD manufacturer with distribution across Latin America; comparable to Biomedica in molecular and clinical chemistry reagent distribution, especially in cross-border LATAM lab supply.

Broad incumbents

• Roche Diagnostics Brasil: Global IVD leader with direct sales in Brazil across molecular diagnostics (cobas, LightCycler) and immunoassays; competes with Biomedica for Brazilian lab PCR and screening contracts but with a much broader portfolio.
• Abbott Diagnostics Brasil: Multinational IVD manufacturer with established Brazil presence in molecular (m2000, Alinity m) and immunoassay platforms; competes with Biomedica across lab segments where PCR and rapid testing intersect.
• Bio-Rad Laboratories Brasil: Global life science and diagnostics company with PCR/qPCR instruments and reagents sold into Brazilian labs; overlaps directly with Biomedica's DT Prime platform and molecular reagent offering.
• QIAGEN Brasil: Global molecular diagnostics and sample technologies vendor with a Brazilian subsidiary; competes with Biomedica on PCR extraction kits, HPV testing workflows, and molecular lab solutions.
• Cepheid (Danaher): Molecular diagnostics incumbent (GeneXpert) with strong Brazilian lab footprint in infectious disease and HPV PCR; competes with Biomedica's DT Prime platform for high-throughput PCR placements.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/mara.biomedica.1
• LinkedInlinkedin.com/company/biomedica-equipamentos-suprimentos-hospitalares
• Instagraminstagram.com/biomedica_diagnostico

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biomedica